PENN042i-258-12
** The karyotype for this cell line may contain a non-clonal finding known to be recurrent in pluripotent stem cells. Please see the karyotype report in the currently distributing lot(s) Product Information & Testing PDF(s) linked below for more information.| Cell Line Alias | iPS-258-SeV12 |
| Cell Type | Human iPS |
| Disease | None reported |
| Sex | Male |
| Age at Collection | 21 Years |
| Ethnicity | Caucasian |
| Ethnicity Information | Self-reported |
| Genetically Related Cell Lines | |
| Reprogramming Method | Non-integrating (Sendai: Oct4, Klf4, Sox2, cMyc) |
| Tissue Origin | Blood |
| Provider | University of Pennsylvania - Dr. Daniel Rader |
| dbGaP Data | |
| hPSCReg ID | |
| NIH Approval | |
| Pub Med Abstract | |
| Collection(s) | NHLBI Next Gen - Lipid Conditions (Dr. Daniel Rader, University of Pennsylvania) |
Current Lot Information
| Lot Number | Culture Platform | Lot Description | Passage Number | Banked By | Protocol | Product Information & Testing |
|---|---|---|---|---|---|---|
| DB34949 | Stem Cell Culture Medium (KOSR/MEF) | 12 | Provider | WiCell Feeder Based (MEF) Pluripotent Stem Cell Protocol |
